Showing results (551-560 of 6,290) with videos related to

Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|February 16, 2010
Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in miceM Perreault, S Will, D Panza, et al.
Diabetes, Obesity & Metabolism|June 10, 2017
Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventionsRonan Roussel, Philippe Gabriel Steg, Kamel Mohammedi, et al.
Diabetes, Obesity & Metabolism|June 10, 2017
A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodentsPia K Nørregaard, Maria A Deryabina, Pernille Tofteng Shelton, et al.
Diabetes, Obesity & Metabolism|May 31, 2017
Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trialShawn E McCandless, Jack A Yanovski, Jennifer Miller, et al.
Diabetes, Obesity & Metabolism|August 12, 2018
The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver diseaseEdward S Chambers, Claire S Byrne, Annette Rugyendo, et al.
Diabetes, Obesity & Metabolism|July 24, 2018
Myocardial infarction is sufficient to increase GLP-1 secretion, leading to improved left ventricular contractility and mitochondrial respiratory capacitySebastian Diebold, Julia Moellmann, Florian Kahles, et al.
Diabetes, Obesity & Metabolism|August 4, 2018
Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: Is low-grade inflammation the neglected component?Francesco Prattichizzo, Valeria De Nigris, Stefano Micheloni, et al.
Diabetes, Obesity & Metabolism|August 11, 2018
Enterically delivered insulin tregopil exhibits rapid absorption characteristics and a pharmacodynamic effect similar to human insulin in conscious dogsJustin M Gregory, Margaret Lautz, Lindsey M Moore, et al.
Diabetes, Obesity & Metabolism|August 14, 2018
Comparison of healthcare resource utilization and costs in patients with type 2 diabetes initiating dapagliflozin versus sitagliptinEmily D Parker, Eric T Wittbrodt, Jeffrey T McPheeters, et al.
Diabetes, Obesity & Metabolism|August 17, 2018
Efficacy and safety of MYL-1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 studyThomas C Blevins, Abhijit Barve, Bin Sun, et al.
Pageof 629